Stocks of the Hour: Resources & Energy Group, WA1 Resources, ImpediMed
Stocks of the Hour: Resources & Energy Group, WA1 Resources, ImpediMed
Resources & Energy Group (ASX:REZ) announced that their opening drilling campaign has confirmed nickel sulphides at their Springfield Nickel Prospect in WA. MD and CEO, J. Daniel Moore commented, "[the 100%-owned package we have today has] opened the way to modern approaches for exploration and the sorts of drill hits we are now enjoying." Shares are trading 200 per cent higher at 3.6 cents.
WA1 Resources (ASX:WA1) has released similar news, announcing that their 2023 drilling program has recorded the highest grade niobium intersection to date at their West Arunta Project in WA. MD, Paul Savich, commented: ""These latest assay results now demonstrate that Luni has a large and extremely high-grade niobium footprint which we are working to extend further." Shares are trading 31.98 per cent higher at $6.19.
ImpediMed (ASX:IPD) announces its first published medical policy from a Blue Cross Blue Shield Health plan covering L-Dex. MD and CEO Richard Valencia said, "we continue to see the response and action by payers accelerate on an almost daily basis and a new BCBS policy will no doubt further accelerate payor momentum." Shares are trading 7.14 higher at 15 cents.
Resources & Energy Group (ASX:REZ) announced that their opening drilling campaign has confirmed nickel sulphides at their Springfield Nickel Prospect in WA. MD and CEO, J. Daniel Moore commented, "[the 100%-owned package we have today has] opened the way to modern approaches for exploration and the sorts of drill hits we are now enjoying." Shares are trading 200 per cent higher at 3.6 cents.
Resources & Energy Group (ASX: REZ) 宣佈,他們的開場鑽探活動已確認其位於西澳大利亞州斯普林菲爾德鎳礦勘探區的硫化鎳。總經理兼首席執行官J. Daniel Moore評論說:“[我們今天擁有的100%擁有的一攬子計劃] 爲現代勘探方法和我們現在享受的鑽探命中開闢了道路。”股價上漲200%,至3.6美分。
WA1 Resources (ASX:WA1) has released similar news, announcing that their 2023 drilling program has recorded the highest grade niobium intersection to date at their West Arunta Project in WA. MD, Paul Savich, commented: ""These latest assay results now demonstrate that Luni has a large and extremely high-grade niobium footprint which we are working to extend further." Shares are trading 31.98 per cent higher at $6.19.
WA1 Resources (ASX: WA1) 也發佈了類似的消息,宣佈其2023年的鑽探計劃在西澳大利亞州的西阿倫塔項目記錄了迄今爲止品位最高的鈮交叉點。醫學博士保羅·薩維奇評論說:“這些最新的化驗結果現在表明,Luni擁有龐大且極高品位的鈮足跡,我們正在努力進一步擴大這一足跡。”股價上漲31.98%,至6.19美元。
ImpediMed (ASX:IPD) announces its first published medical policy from a Blue Cross Blue Shield Health plan covering L-Dex. MD and CEO Richard Valencia said, "we continue to see the response and action by payers accelerate on an almost daily basis and a new BCBS policy will no doubt further accelerate payor momentum." Shares are trading 7.14 higher at 15 cents.
ImpediMed (ASX: IPD) 宣佈了藍十字藍盾健康計劃中首次發佈的涵蓋L-Dex的醫療政策。總經理兼首席執行官理查德·瓦倫西亞說:“我們繼續看到付款人的反應和行動幾乎每天都在加速,BCBS的新政策無疑將進一步加速付款人的勢頭。”股價上漲7.14美元,至15美分。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧